Anti-MRPL16 Antibody (A99288)

Name: Anti-MRPL16 Antibody
Brand: Antibodies.com
SKU: A99288
Price: 185.0 USD
Availability: InStock

Enlarge Image

$185

Rabbit polyclonal antibody to MRPL16 for WB, IHC and ELISA.

100% Guarantee

Price Match Guarantee

Delivery

Freight Charges

$40 to United States

Lead Time

5-8 Business Days

Contact Us

Telephone

+1 (314) 370-6046

orders@antibodies.com

Guarantees

100% Quality Guarantee

Price Match Guarantee

Specifications

Name

Anti-MRPL16 Antibody

Description

Rabbit polyclonal antibody to MRPL16.

Applications

WB, IHC, ELISA

Dilutions

WB: 1:500-1:1000, IHC: 1:50-1:100, ELISA: 1:40000

Reactivity

Human

Immunogen

Synthetic peptide derived from human MRPL16 (amino acids 171-220).

Host

Rabbit

Clonality

Polyclonal

Isotype

IgG

Conjugate

Unconjugated

Purification

Purified from rabbit serum by antigen affinity chromatography using the immunizing peptide.

Molecular Weight

28kDa

Product Form

Liquid

Formulation

Supplied in Phosphate Buffered Saline (without Mg2+ and Ca2+), pH 7.4, with 150mM NaCl, 0.02% Sodium Azide, and 50% Glycerol.

Storage

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Synonyms

39S ribosomal protein L16, 39S ribosomal protein L16 mitochondrial, L16mt, mitochondrial, Mitochondrial ribosomal protein L16, MRP-L16, PNAS 111, RM16_HUMAN

Isotype Controls

Suitable Secondaries

See all Anti-Rabbit IgG Secondaries →

Disclaimer

This product is for research use only. It is not intended for diagnostic or therapeutic use.

Scientific Validation Data (3)

Enlarge Image

Figure 1: Western Blot - Anti-MRPL16 Antibody (A99288)

Western blot analysis of lysates from 293 cells using Anti-MRPL16 Antibody. The right hand lane represents a negative control, where the antibody is blocked by the immunising peptide.

Enlarge Image

Figure 2: Immunohistochemistry - Anti-MRPL16 Antibody (A99288)

Immunohistochemical analysis of paraffin-embedded human heart tissue using Anti-MRPL16 Antibody. The right hand panel represents a negative control, where the antibody was pre-incubated with the immunising peptide.